Over 20,000 Aussies are diagnosed with breast cancer every year and is the most commonly diagnosed cancer among women in…
Digital microscopic imaging company Optiscan (ASX: OIL) has gotten feedback from the US Food and Drug Administration (FDA) in relation…
Would you call selling your intellectual property to your own company a boss move? For Managing Director, Prof Camile Farah,…
With increasing health awareness across China, medtech company Optiscan (ASX: OIL) is set to increase the exposure of their in…